Abstract
Rapid advances have revolutionized the understanding of the pathogenesis of inflammatory bowel disease and targeted therapy. Further translational advances are anticipated. Management of dyspepsia has de-emphasized reliance on unnecessary endoscopy, and it is likely that the resulting increase in availability of endoscopy capacity will be used in colorectal cancer screening. Wireless capsule endoscopy is now established as the best method to visualize the small intestine either in the diagnosis of gastrointestinal haemorrhage or small intestinal Crohn's disease. Risk of gastrointestinal haemorrhage while on antiplatelet agents is being re-evaluated. Statins have been found to be useful in prevention of colorectal cancer risk, adding to potential chemopreventive agents available for this common cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 1-4 |
| Number of pages | 4 |
| Journal | Medicine (United Kingdom) |
| Volume | 31 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2003 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'What's new in... Gastroenterology'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver